Skip to main content
Article thumbnail
Location of Repository

ANG-1 TIE-2 and BMPR Signalling Defects Are Not Seen in the Nitrofen Model of Pulmonary Hypertension and Congenital Diaphragmatic Hernia

By Harriet Jane Corbett, Marilyn Gwen Connell, David Garth Fernig, Paul Damion Losty and Edwin Chitran Jesudason
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2006). Airway smooth muscle dysfunction precedes teratogenic congenital diaphragmatichernia and may contribute to hypoplasticlungmorphogenesis.
    2. (2002). Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons.
    3. (2002). Angiopoietin-1 and VEGF in vascular development and angiogenesis in hypoplastic lungs.
    4. (2000). Angiopoietin-1 protects the adult vasculature against plasma leakage.
    5. (2001). BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.
    6. (2005). Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
    7. (2005). Bone morphogenetic protein receptor-2 and pulmonary arterial hypertension: unraveling a riddle inside an enigma?
    8. (2000). Cell proliferation and apoptosis in experimental lung hypoplasia.
    9. (2009). Cellular and molecular basis of pulmonary arterial hypertension.
    10. (1998). Comparison of the pulmonary vasculature in newborns and stillborns with congenital diaphragmatic hernia.
    11. (2008). Congenital diaphragmatic hernia - the neonatal period (part I).
    12. (1985). Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair.
    13. (2010). Defective angiogenesis in hypoplastic human fetal lungs correlates with nitric oxide synthase deficiency that occurs despite enhanced angiopoietin-2 and VEGF.
    14. (2006). Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension.
    15. (2005). Dysfunctional Smad signaling contributes to Abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    16. (2000). Early lung malformations in congenital diaphragmatic hernia.
    17. (1998). Effect of dexamethasone on endothelial nitric oxide synthase in experimental congenital diaphragmatic hernia.
    18. (1998). Effect of prenatal glucocorticoids on pulmonary vascular muscularisation in nitrofen-induced congenital diaphragmatic hernia.
    19. (2003). Expression of heme oxygenase-1 and endothelial nitric oxide synthase in the lung of newborns with congenital diaphragmatic hernia and persistent pulmonary hypertension.
    20. (2008). Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.
    21. (2001). Fetal tracheal occlusion in the rat model of nitrofen-induced congenital diaphragmatic hernia: tracheal occlusion reverses the arterial structural abnormality.
    22. (2000). Heparin and in-vitro experimental lung hypoplasia.
    23. (2000). Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.
    24. (2004). Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension.
    25. (2000). In vitro effects of growth factors on lung hypoplasia in a model of congenital diaphragmatic hernia.
    26. (2008). Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature.
    27. (1998). Inhibition of vascular and epithelial differentiation in murine nitrofen-induced diaphragmatic hernia.
    28. (2007). Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction.
    29. (2003). Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
    30. (2006). Nitric oxide for respiratory failure in infants born at or near term.
    31. (1997). Nitrofen dosedependent gestational day-specific murine lung hypoplasia and left-sided diaphragmatic hernia.
    32. (1990). Nitrofeninduced diaphragmatic hernias in rats: an animal model.
    33. (2007). Prenatal detection and outcome of congenital diaphragmatic hernia: a French registry-based study.
    34. (2003). Protective role of angiopoietin-1 in experimental pulmonary hypertension.
    35. (1992). Pulmonary vascular abnormalities in experimentally induced congenital diaphragmatic hernia in rats.
    36. (2006). Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
    37. (2004). Signal transduction of bone morphogenetic protein receptors.
    38. (2006). Signaling and functions of angiopoietin-1 in vascular protection.
    39. (2003). Signaling molecules in nonfamilial pulmonary hypertension.
    40. (2005). Smad1 expression and function during mouse embryonic lung branching morphogenesis. Am J Physiol Lung Cell Mol Physiol 288: L1033–1039. Signalling in Congenital Diaphragmatic Hernia PLoS
    41. (2011). Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?
    42. (2005). Suppression of type II bone morphogenic protein receptor in vascular smooth muscle induces pulmonary arterial hypertension in transgenic mice.
    43. (2012). Targeted gene delivery of BMPR-2 attenuates pulmonary hypertension.
    44. (2006). Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension.
    45. (2006). The ´re `se P
    46. (2009). The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.